Eli Lilly (LLY) Offering Possible 34.77% Return Over the Next 15 Calendar Days

This article was originally published on this site

Eli Lilly’s most recent trend suggests a bullish bias. One trading opportunity on Eli Lilly is a Bull Put Spread using a strike $160.00 short put and a strike $155.00 long put offers a potential 34.77% return on risk over the next 15 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $160.00 by expiration. The full premium credit of $1.29 would be kept by the premium seller. The risk of $3.71 would be incurred if the stock dropped below the $155.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Eli Lilly is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Eli Lilly is bullish.

The RSI indicator is at 63.44 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Eli Lilly

Top Analyst Reports for Visa, JPMorgan & Bank of America
Tue, 30 Jun 2020 17:21:05 +0000
Top Analyst Reports for Visa, JPMorgan & Bank of America

Canada federal court dismisses drugmakers’ plea challenging drug price rules
Mon, 29 Jun 2020 22:57:59 +0000
The federal court of Canada on Monday dismissed a plea by drugmakers challenging the Canadian government’s new regulations aimed at lowering prices of patented drugs that could potentially lead them to lose billions over a decade. The court struck down one part of the new regulation, finding that using certain payments to third parties to determine a drug’s regulated price went beyond the government’s authority, but upheld the bulk of the rules. Canada published the final regulations in August last year, despite strong opposition from drug companies.

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
Mon, 29 Jun 2020 21:45:09 +0000
In the latest trading session, Eli Lilly (LLY) closed at $162.72, marking a -0.07% move from the previous day.

These 6 health-care stocks are ‘buys’ because they can thrive under either Trump or Biden
Mon, 29 Jun 2020 11:47:00 +0000
Target shares of innovative companies whose products and services will gain in popularity no matter what changes are made to the U.S. health-care system.

The Zacks Analyst Blog Highlights: LLY, ABBV, NBIX and RDY
Thu, 25 Jun 2020 16:17:04 +0000
The Zacks Analyst Blog Highlights: LLY, ABBV, NBIX and RDY

Be Sociable, Share!

Related Posts